West Pharmaceutical Services, Inc.: how funds voted at the meeting of 4 May 2026
- Ticker
- WST
- Meeting
- Season
- year to 30 June 2026
- Filers reporting
- 904
- Ballot items
- 5
904 filers on Form N-PX reported votes at the West Pharmaceutical Services, Inc. meeting of 4 May 2026. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2026. Filings read through . How the figures are made
The ballot
Item 1: Director elections
11 nominees. 94.0% of the reported votes are for. 27 filers withheld from or voted against at least one nominee.
7,551 vote records from 248 filers. 4 of the 247 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 50 fund families
- For 50
Item 2: Advisory vote on executive pay (say-on-pay)
1,505 vote records from 899 filers. 58 of the 870 filers that marked the item voted against management. 29 filers gave no management mark.
- Positions of 53 fund families
- For 53
Item 3: Audit-related items (auditor ratification)
685 vote records from 247 filers. 4 of the 246 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 50 fund families
- For 50
Item 4: Shareholder proposal regarding an independent Board Chair policy.
665 vote records from 242 filers. 126 of the 241 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 50 fund families
- For 29
- Against 21
- Against management 30
Item 5: Shareholder proposals (not separable from the filings)
Filers described these proposals in different words that the site could not match, so they are shown together.
1 vote record from 1 filer. 1 of the 1 filer that marked the item voted against management.
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Auditor | 4. Proposal |
|---|---|---|---|
| AllianceBernstein | For | For | For, against management |
| Allspring | For | For | For, against management |
| American Century | For | For | Against |
| Artisan Partners | For | For | Against |
| Baird | For | For | For, against management |
| BlackRock and iShares | For | For | Against |
| BNY Mellon | For | For | Against |
| Brighthouse Funds | For | For | For, against management |
| Capital Group and American Funds | For | For | For, against management |
| Charles Schwab | For | For | Against |
| Columbia Threadneedle | For | For | For, against management |
| Dimensional | For | For | Against |
| DWS | For | For | For, against management |
| Equitable | For | For | For, against management |
| Federated Hermes | For | For | For, against management |
| Fidelity | For | For | Against |
| First Trust | For | For | For, against management |
| Franklin Templeton | For | For | For, against management |
| Global X | For | For | For, against management |
| Goldman Sachs | For | For | Against |
| Guggenheim and Rydex | For | For | For, against management |
| Hartford Funds | For | For | For, against management |
| Invesco | For | For | For, against management |
| J.P. Morgan | For | For | Against |
| Jackson National funds | For | For | For, against management |
| Janus Henderson | For | No report | No report |
| John Hancock and Manulife | For | For | Against |
| Lincoln Financial | For | For | Against, against management |
| Macquarie and Delaware Funds | For | No report | No report |
| MassMutual | For | For | For, against management |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For, against management |
| Nationwide | For | For | For, against management |
| Natixis and Loomis Sayles | For | No report | No report |
| Neuberger Berman | For | For | For, against management |
| Northern Trust and FlexShares | For | For | Against |
| Nuveen and TIAA | For | For | Against |
| Pacific Life funds | For | For | Against |
| PGIM and Prudential | For | For | For, against management |
| PIMCO | For | For | For, against management |
| Principal | For | For | Against |
| ProShares and ProFunds | For | For | For, against management |
| Russell Investments | For | For | For, against management |
| SEI | For | For | For, against management |
| State Street and SPDR | For | For | Against |
| T. Rowe Price | For | For | For, against management |
| Thrivent | For | For | Against |
| Transamerica | For | For | Against |
| VanEck | For | For | For, against management |
| Vanguard | For | For | Against |
| Victory Capital | For | For | For, against management |
| Virtus | For | For | For, against management |
| Voya | For | For | Against |
| WisdomTree | For | For | Against |
Questions
- How many filers reported votes at the West Pharmaceutical Services, Inc. meeting?
- 904 Form N-PX filers reported votes at the meeting of 4 May 2026. On say-on-pay, 58 of 870 filers that marked the item voted against management (6.7%). The filings show one separate proposal from security holders.
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. West Pharmaceutical Services, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list West Pharmaceutical Services, Inc. with a meeting date within three days of 4 May 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .